CD70 | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Car-T cells attacking cancer cell

Trial results

5 December 2023

Crispr abandons first-generation Car-T projects

The company hopes that new edits could solve the relapse problem with allogeneic Car-Ts.

Subscribe to CD70